Key result
Male gender was associated with higher disease severity and significantly lower median Hammersmith Functional Rating Scale Expanded scores compared to females (16 vs 40; p=0.0040) in adult SMA.
Why the study?
The natural history of spinal muscular atrophy in adulthood has not been fully elucidated, including factors predicting disease progression and response to treatments.
Does gender affect disease severity and motor function in untreated adults with spinal muscular atrophy?
Cross-Sectional (n=165)
Does gender affect disease severity and motor function in untreated adults with spinal muscular atrophy?
Absolute Event Rate: 16% vs 40%
p-value: p=0.0040
In adult patients with spinal muscular atrophy, male gender is associated with higher disease severity and worse motor function compared to females.
Background Natural history of spinal muscular atrophy (SMA) in adult age has not been fully elucidated yet, including factors predicting disease progression and response to treatments. Aim of this retrospective, cross-sectional study, is to investigate motor function across different ages, disease patterns and gender in adult SMA untreated patients. Methods Inclusion criteria were as follows: (1) clinical and molecular diagnosis of SMA2, SMA3 or SMA4 and (2) clinical assessments performed in adult age (>18 years). Results We included 64 (38.8%) females and 101 (61.2%) males (p=0.0025), among which 21 (12.7%) SMA2, 141 (85.5%) SMA3 and 3 (1.8%) SMA4. Ratio of sitters/walkers within the SMA3 subgroup was significantly (p=0.016) higher in males (46/38) than in females (19/38). Median age at onset was significantly (p=0.0071) earlier in females (3 years; range 0–16) than in males (4 years; range 0.3–28), especially in patients carrying 4 SMN2 copies. Median Hammersmith Functional Rating Scale Expanded scores were significantly (p=0.0040) lower in males (16, range 0–64) than in females (40, range 0–62); median revised upper limb module scores were not significantly (p=0.059) different between males (24, 0-38) and females (33, range 0–38), although a trend towards worse performance in males was observed. In SMA3 patients carrying three or four SMN2 copies, an effect of female sex in prolonging ambulation was statistically significant (p=0.034). Conclusions Our data showed a relevant gender effect on SMA motor function with higher disease severity in males especially in the young adult age and in SMA3 patients.
No takes yet. Share an insight, caveat, or question.
Maggi et al. (2022) conducted a cross-sectional in Spinal muscular atrophy (SMA) (n=165). Male gender vs. Female gender was evaluated on Hammersmith Functional Rating Scale Expanded (HFMSE) scores (p=0.0040). Male gender was associated with higher disease severity and significantly lower median Hammersmith Functional Rating Scale Expanded scores compared to females (16 vs 40; p=0.0040) in adult SMA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: